AbbVie’s JUVMO (tavapadon) targets dopamine differently from older drugs and is expected in US pharmacies this month, the ...

Alan Alda is opening up about his sleep disorder symptoms. In a new interview with CBS Mornings, Alda shared how he was ...

Tavapadon (Juvmo) is a new once-daily pill for Parkinson’s motor symptoms. Here’s how it works, who it may help and what to ...

The Parkinson's disease market is expected to grow steadily, driven by the recent approval of AbbVie's JUVMO along with the rising prevalence of the ...

Phreesia is supporting The Michael J. Fox Foundation to raise educational awareness and research onramps for the Parkinson’s disease community.

MAS*H star Alan Alda has revealed a bizarre sleep habit was the first warning sign of Parkinson’s disease, long before he ...

More than 1 million people in the U.S. are currently living with Parkinson's disease. CBS News New York sports producer Joe McLaughlin shared his Parkinson's journey with Kristine Johnson.

The protein alpha-synuclein is abundant in healthy brains and plays an important role in enabling communication between nerve ...

The star said he was physically 'acting out [his] dreams' before he learned he had the neurodegenerative disease.

Bringing Reimbursable, Continuous Parkinson’s Monitoring into Clinical WorkflowsWASHINGTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- NeuroRPM, a provider of FDA-cleared, AI-enabled wearable technology for ...

The timing of deep brain stimulation (DBS) surgery is a critical factor in preserving cognitive function for Parkinson's ...

Tavapadon, a treatment for Parkinson’s disease recently approved by the FDA, provides a novel option for healthcare providers ...